This Article Full Text (PDF) All Versions of this Article: 0269881107079866v1 22/2/132    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pinheiro, S. Articles by Graeff, F. Search for Related Content PubMed PubMed Citation Articles by Pinheiro, S. Articles by Graeff, F. Social Bookmarking                         What's this?

Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze

Division of Psychiatry, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil

CM Del-Ben

Division of Psychiatry, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil

H. Zangrossi, Jr

Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil

FG Graeff

Division of Psychiatry, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, fgraeff{at}keynet.com.br

Escitalopram is a highly selective inhibitor of serotonin re—uptake that is used to treat anxiety disorders. In the present study, we investigated the effects of acute, sub-chronic (14 days) and chronic (21 days) administration of escitalopram (2, 4 and 8 mg/kg, PO) on the performance of rats in the elevated T-maze. For comparison, imipramine (15 mg/kg, PO) was also studied. The apparatus is made of three elevated arms of equal dimension, one enclosed transversal to the two open arms. Inhibitory avoidance of the open arms, trained in the enclosed arm, has been related to generalised anxiety disorder, while one-way escape from one open arm, to panic disorder. After acute administration, the three doses of escitalopram impaired avoidance (anxiolytic effect), while imipramine was ineffective. Escape was unaffected by either drug. With subchronic administration, both drugs were ineffective on either avoidance or escape. After chronic treatment, avoidance was impaired by imipramine and by the two highest doses of escitalopram. In addition, escape was impaired (panicolytic effect) by imipramine and by the highest dose of escitalopram. Locomotion measured in a square arena was increased by the three doses of escitalopram, given chronically. Therefore, both imipramine and escitalopram had anxiolytic and panicolytic-like effects after chronic administration, but acutely only escitalopram decreased anxiety. Since no such effect was observed following subchronic administration, it is likely that the mechanisms of the early and late anxiolytic actions of escitalopram are different.

Key Words: serotonin • anxiety • panic • animal model

This version was published on March 1, 2008

Journal of Psychopharmacology, Vol. 22, No. 2, 132-137 (2008)
DOI: 10.1177/0269881107079866


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?